Carl Zeiss Meditec AG (ETR:AFX)
23.52
-0.10 (-0.42%)
At close: Mar 16, 2026
Carl Zeiss Meditec AG Market Cap
Carl Zeiss Meditec AG has a market cap or net worth of €2.07 billion as of March 16, 2026. Its market cap has decreased by -61.31% in one year.
Market Cap
2.07B
Enterprise Value
2.59B
Revenue
2.20B
Ranking
n/a
PE Ratio
16.87
Stock Price
€23.52
Market Cap Chart
Since July 30, 2002, Carl Zeiss Meditec AG's market cap has increased from 281.58M to 2.07B, an increase of 634.28%. That is a compound annual growth rate of 8.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 2.07B | -40.95% |
| Dec 30, 2025 | 3.50B | -12.13% |
| Dec 30, 2024 | 3.98B | -54.93% |
| Dec 29, 2023 | 8.84B | -16.17% |
| Dec 30, 2022 | 10.55B | -36.22% |
| Dec 30, 2021 | 16.53B | 69.74% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 46.87B |
| Siemens Healthineers AG | 43.27B |
| Bayer Aktiengesellschaft | 37.96B |
| Fresenius SE & Co. KGaA | 26.37B |
| Fielmann Group AG | 3.57B |
| Ottobock SE & Co. KGaA | 3.41B |
| Dermapharm Holding SE | 2.20B |
| SCHOTT Pharma AG & Co. KGaA | 2.04B |